Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Nature Medicine

Volumn 10, Issue 7, 2004, Pages 719-726

  Koistinaho, Milla ^a   Lin, Suizhen ^a   Wu, Xin ^a   Esterman, Michail ^a   Koger, Deanna ^a   Hanson, Jeffrey ^a   Higgs, Richard ^a   Liu, Feng ^a   Malkani, Seema ^a   Bales, Kelly R ^a   Paul, Steven M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; PHASE CONTRAST MICROSCOPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; ASTROCYTES; CELL AGGREGATION; CELL SURVIVAL; CELLS, CULTURED; LDL-RECEPTOR RELATED PROTEIN 1; MICE; MICE, INBRED C57BL;

ANIMALIA;

EID: 3142781310     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1058     Document Type: Article

References (38)

1. Saunders, A.M. et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472 (1993).
2. Rebeck, G.W., Reiter, J.S., Strickland, D.K. & Hyman, B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580 (1993).
3. Strittmatter, W.J. et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102 (1993).
4. Schmechel, D.E. et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653 (1993).
5. Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17, 263-264 (1997).
6. V717F transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96, 15233-15238 (1999).
7. Holtzman, D.M. et al. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15-R21 (1999).
8. Fagan, A.M. et al. Human and murine apoE markedly influence Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 9, 305-318 (2002).
9. Wyss-Coray, T. et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618 (2001).
10. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6, 916-919 (2000).
11. Bacskai, B.J. et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy. J. Neurosci. 22, 7873-7878 (2002).
12. Frackowiak, J. et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta. Neuropathol. (Berl.) 84, 225-233 (1992).
13. Rogers, J., Strohmeyer, R., Kovelowski, C.J. & Li, R. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide. Glia 40, 260-269 (2002).
14. Wisniewski, H.M., Wegiel, J., Wang, K.C., Kujawa, M. & Lach, B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16, 535-542 (1989).
15. Wisniewski, H.M., Wegiel, J. & Kotula, L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22, 3-11 (1996).
16. Wegiel, J. et al. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging 22, 49-61 (2001).
17. Meda, L. et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650 (1995).
18. Giulian, D. et al. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037 (1996).
19. Qin, L. et al. Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973-983 (2002).
20. Shao, Y. & McCarthy, K.D. Plasticity of astrocytes. Glia 11, 147-155 (1994).
21. Montgomery, D.L. Astrocytes: form, functions, and roles in disease. Vet. Pathol. 31, 145-167 (1994).
22. Hatten, M.E., Liem, R.R.M., Shelanset, M.L. & Mason, C.A. Astroglia in CNS injury. Glia 4, 233-243 (1991).
23. Al-Ali, S.Y. & Al-Hussain, S.M. An ultrastructural study of the phagocytic activity of astrocytes in adult rat brain. J. Anat. 188, 257-262 (1996).
24. Guillaume, D., Bertrand, P., Dea, D. & Poirier, J. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform specific alterations. J. Neurochem. 66, 2410-2418 (1996).
25. Funato, H. et al. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am. J. Pathol. 152, 983-992 (1998).
26. Matsunaga, W., Shirokawa, T. & Isobe, K. Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microglia. Neurosci. Lett. 342, 129-131 (2003).
27. Wegiel, J., Wang, K.C., Tarnawsk, M. & Lach, B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta. Neuropathol. (Berl). 100, 356-364 (2000).
28. Wyss-Coray, T. et al. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat Med. 9, 453-457 (2003).
29. Nitta, T., Yagita, H., Sato, K. & Okumura, K. Expression of Fc γ receptors on astroglial cell lines and their role in the central nervous system. Neurosurgery 31, 8347-87 (1992).
30. Warshawsky, I., Bu, G. & Schwartz, A.L. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J. Clin. Invest. 92, 937-944 (1993).
31. Gylys, K.H., Fein, J.A., Tan, A.M. & Cole, G.M. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals. J. Neurochem. 84, 1442-1451 (2003).
32. Urmoneit, B. et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77, 157-166 (1997).
33. Thal, D.R. et al. Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex. Acta. Neuropathol. 100, 608-617 (2000).
34. Yamaguchi, H., Sugihara, S., Ogawa, A., Saido, T.C. & Ihara, Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta. Neuropathol. 95, 217-222 (1998).
35. De Groot, C.J. et al. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342-354 (1997).
36. Saura, J., Petegnief, V., Wu, X., Liang, Y. & Paul, S.M. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J. Neurochem. 85, 1455-1467 (2003).
37. Marr, R.A. et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23, 1992-1996 (2003).
38. Manders, E.E.M., Verbeek, F.J. & Aten, J.A. Measurement of co-localisation of objects in dual-colour images. J. Microsc. 169, 375-382 (1993).